Login / Signup

Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability Study.

Hninyee WinSamantha RussellBetsy C WertheimVictoria MaizesRobert L CrockerAudrey J BrooksRuben A MesaJennifer L HubertyHolly L GeyerRyan EckertAshley LarsenKrisstina Gowin
Published in: JMIR formative research (2022)
Our 12-week intervention with the MWC app was feasible and was associated with a decrease in MPN symptom burden. Further investigation of the MWC app for use as a self-management strategy to reduce the symptom burden in patients with MPN is warranted.
Keyphrases
  • randomized controlled trial
  • patient reported
  • risk factors
  • study protocol
  • low grade